Researchers have announced a breakthrough treatment that allows damaged hearts to be patched with living muscle, offering new hope to millions of people suffering from advanced heart failure.
The Global Challenge of Heart Failure
Heart failure currently affects more than 64 million people worldwide, caused by conditions such as heart attacks, high blood pressure, and coronary artery disease. Treatment options remain limited: heart transplants face a shortage of donor organs, while artificial pumps are costly and often lead to serious complications.
A Biological Transplant for the First Time
Scientists at the University Medical Center Göttingen in Germany have developed implantable patches made of beating heart muscle that help the heart contract.
Prof. Ingo Kutschka, co-author of the study, explained: “For the first time, we now have a laboratory-grown biological transplant that can stabilize and strengthen heart muscle.”
How the Patches Are Made
As reported by the guardian, the process begins by taking cells from blood and reprogramming them into stem cells. These cells are then converted into heart muscle and connective tissue cells, embedded in collagen gel, and grown in specialized moulds. The resulting hexagonal patches are attached in arrays to a membrane measuring about 5 cm by 10 cm for human use.
Prof. Wolfram-Hubertus Zimmermann noted that the tissue resembles heart muscle aged four to eight years old, effectively implanting “young” muscle into failing hearts.
Why Patches Work Better Than Injections
Earlier attempts to inject heart muscle cells directly into the heart often caused dangerous side effects such as tumor growth or irregular heartbeats. By contrast, the patches deliver a larger number of cells with higher retention and no evidence of harmful complications.
Successful Trials in Monkeys and Humans
Writing in Nature, the team reported successful testing of patches in healthy rhesus macaques. No signs of arrhythmias, tumors, or related diseases were found, even six months after implantation. The patches caused a thickening of the heart wall, with improvements depending on the number of patches applied.
In monkeys with a condition similar to chronic heart failure, the patches improved heart function by strengthening wall contractions.
The researchers also applied the approach to a 46-year-old woman with advanced heart failure. Using donor-derived human cells, they sutured the patches to her beating heart through minimally invasive surgery. Three months later, when the patient received a heart transplant, the removed organ showed that the patches had survived and developed a blood supply.
Toward Wider Use in Patients
So far, 15 patients have received heart patches, though immune suppression is required when using donor cells. Researchers argue that donor-derived, “off-the-shelf” patches are more practical than creating patient-specific patches, which are time-consuming and costly.
According to Kutschka, the therapeutic effects appear after three to six months, meaning the patches may not suit patients needing immediate treatment. However, the ongoing clinical trial aims to confirm whether engineered muscle grafts can significantly improve cardiac function.
A New Option Beyond Transplants
Zimmermann emphasized that the patches are not intended to replace heart transplants but rather to offer a lifeline for patients under palliative care, who currently face a 50% mortality rate within 12 months.
Expert Reactions
Independent experts hailed the findings as a major step forward.
- Prof. Sian Harding (Imperial College London) called the research groundbreaking but urged further work to improve muscle maturity and blood flow.
- Prof. Ipsita Roy (University of Sheffield) praised the approach, highlighting its less invasive nature compared to heart transplants. “The concept is clear—you can patch up the heart wherever it is damaged,” she said.